Holen Sie sich die Stockscreener-App
7.68
1.16%
-0.09
Schlusskurs vom Vortag:
$7.77
Offen:
$7.72
24-Stunden-Volumen:
3.03M
Relative Volume:
0.45
Marktkapitalisierung:
$1.36B
Einnahmen:
$2.54B
Nettoeinkommen (Verlust:
$-207.36M
KGV:
-6.4538
EPS:
-1.19
Netto-Cashflow:
$151.25M
1W Leistung:
-1.79%
1M Leistung:
+11.79%
6M Leistung:
-13.51%
1J Leistung:
+0.79%
1-Tages-Spanne:
$7.61
$7.75
1-Wochen-Bereich:
$7.47
$7.90
52-Wochen-Spanne:
$6.35
$15.21
Teladoc Health Inc Stock (TDOC) Company Profile
Firmenname
Teladoc Health Inc
Sektor
Branche
Telefon
(203) 635-2002
Adresse
155 E 44TH STREET, NEW YORK, NY
Vergleichen Sie TDOC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
7.68 | 1.32B | 2.54B | -207.36M | 151.25M | -1.19 |
|
VEEV
Veeva Systems Inc
|
276.43 | 45.01B | 2.97B | 809.93M | 1.33B | 4.87 |
|
TEM
Tempus Ai Inc
|
86.38 | 13.58B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
71.03 | 12.92B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
92.49 | 7.88B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.36 | 7.06B | 906.14M | -52.62M | 89.62M | -0.3621 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-25 | Eingeleitet | Mizuho | Neutral |
| 2024-11-15 | Eingeleitet | Goldman | Buy |
| 2024-09-17 | Bestätigt | Jefferies | Hold |
| 2024-02-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-17 | Herabstufung | DA Davidson | Buy → Neutral |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-02-23 | Hochstufung | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | Hochstufung | Guggenheim | Sell → Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-17 | Herabstufung | Guggenheim | Neutral → Sell |
| 2022-08-12 | Eingeleitet | DA Davidson | Buy |
| 2022-08-02 | Herabstufung | Berenberg | Buy → Hold |
| 2022-08-02 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-07-28 | Herabstufung | Goldman | Buy → Neutral |
| 2022-07-28 | Herabstufung | Needham | Buy → Hold |
| 2022-07-06 | Bestätigt | BofA Securities | Neutral |
| 2022-05-05 | Herabstufung | Argus | Buy → Hold |
| 2022-04-28 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-28 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2022-04-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-04-28 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-03 | Hochstufung | Argus | Hold → Buy |
| 2022-02-23 | Bestätigt | BofA Securities | Neutral |
| 2022-02-23 | Bestätigt | Craig Hallum | Hold |
| 2022-02-23 | Bestätigt | Evercore ISI | In-line |
| 2022-02-23 | Bestätigt | Goldman | Buy |
| 2022-02-23 | Bestätigt | JP Morgan | Overweight |
| 2022-02-23 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | Bestätigt | Needham | Buy |
| 2022-02-23 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-23 | Bestätigt | Stifel | Hold |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2022-02-08 | Bestätigt | Piper Sandler | Overweight |
| 2021-12-02 | Fortgesetzt | Jefferies | Hold |
| 2021-11-22 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-10-28 | Bestätigt | Barclays | Equal Weight |
| 2021-10-28 | Bestätigt | BofA Securities | Neutral |
| 2021-10-28 | Bestätigt | Canaccord Genuity | Buy |
| 2021-10-28 | Bestätigt | Citigroup | Buy |
| 2021-10-28 | Bestätigt | Craig Hallum | Hold |
| 2021-10-28 | Bestätigt | Needham | Buy |
| 2021-10-28 | Bestätigt | Oppenheimer | Outperform |
| 2021-10-28 | Bestätigt | Piper Sandler | Overweight |
| 2021-10-28 | Bestätigt | UBS | Neutral |
| 2021-10-19 | Eingeleitet | Wells Fargo | Overweight |
| 2021-08-02 | Herabstufung | Argus | Buy → Hold |
| 2021-07-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-05-28 | Eingeleitet | Robert W. Baird | Neutral |
| 2021-04-15 | Eingeleitet | Needham | Buy |
| 2021-01-07 | Eingeleitet | BTIG Research | Buy |
| 2020-12-22 | Eingeleitet | Evercore ISI | In-line |
| 2020-12-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | Eingeleitet | Goldman | Neutral |
| 2020-11-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | Eingeleitet | DA Davidson | Buy |
| 2020-09-02 | Hochstufung | Berenberg | Hold → Buy |
| 2020-08-17 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-07-13 | Eingeleitet | Argus | Buy |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-04-30 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-03-31 | Herabstufung | Berenberg | Buy → Hold |
| 2020-03-25 | Herabstufung | Craig Hallum | Buy → Hold |
| 2020-03-16 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | Eingeleitet | UBS | Neutral |
| 2020-01-09 | Herabstufung | BofA/Merrill | Buy → Neutral |
Alle ansehen
Teladoc Health Inc Aktie (TDOC) Neueste Nachrichten
Brokerages Set Teladoc Health, Inc. (NYSE:TDOC) Price Target at $9.80 - MarketBeat
Teza Capital Management LLC Trims Stock Holdings in Teladoc Health, Inc. $TDOC - MarketBeat
Teladoc (TDOC) Stock Drops Despite Market Gains: Important Facts to Note - sharewise.com
Invenomic Capital Management LP Boosts Stake in Teladoc Health, Inc. $TDOC - MarketBeat
Teladoc Health (TDOC): Assessing the Latest Valuation After Recent Share Price Momentum - Yahoo Finance
Teladoc Health, Inc. (NYSE:TDOC) is favoured by institutional owners who hold 73% of the company - Yahoo Finance
CEO Change: Is Teladoc Health Inc. a play on infrastructure spendingMarket Growth Summary & Free Technical Confirmation Trade Alerts - Lancaster City Council
Canada Pension Plan Investment Board Grows Stock Holdings in Teladoc Health, Inc. $TDOC - MarketBeat
AI in Telehealth & Telemedicine Market Latest Trends Analysis Report 2025 - InsightAce Analytic
Trexquant Investment LP Purchases 604,116 Shares of Teladoc Health, Inc. $TDOC - MarketBeat
Using portfolio simulators with Teladoc Health Inc. includedJuly 2025 Intraday Action & Low Drawdown Investment Strategies - Newser
What recovery options are there for Teladoc Health Inc.Dip Buying & Fast Gain Swing Trade Alerts - Newser
Is Teladoc Health Inc. trading at a discount2025 Dividend Review & AI Forecasted Entry and Exit Points - خودرو بانک
Can Teladoc Health Inc. expand its profit margins2025 Volume Leaders & Technical Buy Zone Confirmation - خودرو بانک
How high can Teladoc Health Inc. stock goGap Up & Low Risk Entry Point Guides - Newser
Is Teladoc Health Inc. in a bullish channelMarket Movement Recap & Expert Approved Momentum Trade Ideas - خودرو بانک
Navigating the New Normal in the Job Market - AInvest
2 Beaten-Down Stocks to Avoid Right Now - AOL.com
What institutional flow reveals about Teladoc Health Inc.Portfolio Gains Summary & Advanced Technical Analysis Signals - Newser
Virtual Care Market is expected to reach US$ 72.73 Billion by 2033 - openPR.com
What’s next for Teladoc Health Inc. stockMarket Weekly Review & Free Long-Term Investment Growth Plans - خودرو بانک
Short interest data insights for Teladoc Health Inc.July 2025 Market Mood & Precise Buy Zone Tips - Newser
Strategies to average down on Teladoc Health IncWeekly Risk Summary & Safe Entry Momentum Stock Tips - Newser
Sector ETF performance correlation with Teladoc Health Inc.Weekly Stock Summary & Capital Efficient Trading Techniques - Newser
Risk vs reward if holding onto Teladoc Health Inc.2025 Market WrapUp & Free Real-Time Market Sentiment Alerts - Newser
Can technical indicators confirm Teladoc Health Inc.’s reversalMarket Volume Report & Weekly High Return Forecasts - Newser
Will Teladoc Health Inc. stock go up soonAnalyst Downgrade & Community Consensus Stock Picks - Newser
Teladoc Health: The Upside Is Tantalizing, But The Risks Are Too High (NYSE:TDOC) - Seeking Alpha
Teladoc Health Inc. stock momentum explainedJuly 2025 Action & Fast Entry and Exit Trade Plans - Newser
Best data tools to analyze Teladoc Health Inc. stock2025 Trading Recap & Low Risk High Reward Ideas - Newser
Custom strategy builders for tracking Teladoc Health Inc.2025 Support & Resistance & High Conviction Buy Zone Picks - Newser
Buy Signal: Can Teladoc Health Inc. expand its profit marginsRate Cut & Free Real-Time Market Sentiment Alerts - khodrobank.com
Hsbc Holdings PLC Lowers Stake in Teladoc Health, Inc. $TDOC - MarketBeat
Aug Update: What hedge funds are buying Teladoc Health Inc.Weekly Trading Summary & Community Consensus Trade Alerts - خودرو بانک
Will Teladoc Health Inc. benefit from sector rotationMarket Risk Analysis & Technical Buy Zone Confirmation - خودرو بانک
Will earnings trigger a reversal in Teladoc Health Inc.July 2025 Reactions & Capital Efficient Trading Techniques - Newser
Teladoc Health Inc. recovery potential after sell offJuly 2025 Intraday Action & Safe Entry Point Alerts - Newser
Combining price and volume data for Teladoc Health Inc.Global Markets & Weekly Stock Breakout Alerts - Newser
Is Teladoc Health Inc. reversing from oversold territoryWeekly Stock Summary & Community Driven Trade Alerts - Newser
EPS Watch: Is Teladoc Health Inc. a good ESG investmentWeekly Trend Report & Daily Risk Controlled Trade Plans - khodrobank.com
Top 10 Healthcare Apps - Vocal
Price Channel Expanding on Teladoc Health Inc.’s ChartQuarterly Trade Report & Capital Efficiency Focused Strategies - beatles.ru
Finanzdaten der Teladoc Health Inc-Aktie (TDOC)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.30%
0.78%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):